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The axonal initial segment (AIS) is the subcellular compartment required for initiation of the
action potential in neurons. Scaffolding and regulatory proteins at the AIS cluster with ion
channels ensuring the integrity of electrical signaling. Interference with the configuration
of this protein network can lead to profound effects on neuronal polarity, excitability,
cell-to-cell connectivity and brain circuit plasticity. As such, the ability to visualize AIS
components with precision provides an invaluable opportunity for parsing out key
molecular determinants of neuronal function. Fluorescence-based immunolabeling is a
sensitive method for morphological and molecular characterization of fine structures
in neurons. Yet, even when combined with confocal microscopy, detection of AIS
elements with immunofluorescence has been limited by the loss of antigenicity caused by
fixative materials. This technical barrier has posed significant limitations in detecting AIS
components alone or in combination with other markers. Here, we designed improved
protocols targeted to confocal immunofluorescence detection of the AIS marker
fibroblast growth factor 14 (FGF14) in combination with the cytoskeletal-associated
protein Ankyrin-G, the scaffolding protein βIV-spectrin, voltage-gated Na+ (Nav) channels
(especially the Nav1.6 isoform) and critical cell type-specific neuronal markers such as
parvalbumin, calbindin, and NeuN in the mouse brain. Notably, we demonstrate that
intracardiac perfusion of animals with a commercially available solution containing 1%
formaldehyde and 0.5% methanol, followed by brief fixation with cold acetone is an
optimal and sensitive protocol for FGF14 and other AIS marker detection that guarantees
excellent tissue integrity. With variations in the procedure, we also significantly improved
the detection of Nav1.6, a Nav isoform known for its fixative-sensitivity. Overall, this study
provides an ensemble of immunohistochemical recipes that permit excellent staining of
otherwise invisible molecules within well-preserved tissue architecture. While improving
the specific investigation of AIS physiology and cell biology, our thorough study can also
serve as a roadmap for optimizing immunodetection of other fixative-sensitive proteins
expanding the repertoire of enabling methods for brain studies.
Keywords: FGF14, axon initial segment, nodes of Ranvier, immunohistochemistry, sodium channel, Nav1.6,
Ankyrin-G
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INTRODUCTION
The axon initial segment (AIS) is a specialized subcellular
compartment that commences a short distance from the
neuronal soma just past the axon hillock (Duflocq et al., 2011).
The highly organized structure of the enriched mesh of ion
channels and accessory proteins at the AIS is required for
generation of the action potential (Buffington and Rasband,
2011; Duflocq et al., 2011; Yoshimura and Rasband, 2014; Akin
et al., 2015; Papandreou et al., 2015). Cytoskeletal-associated,
scaffolding and regulatory proteins such as Ankyrin-G, βIV-
spectrin, and FGF14 (Ogawa and Rasband, 2008; Duflocq et al.,
2011; Xiao et al., 2013) are localized at the AIS where they cluster
with voltage-gated Na+ (Nav) channels (and other channels)
ensuring the integrity of electrical signaling. Interference with
this protein network can lead to deficits in excitability and
eventually neuronal death (Hsu et al., 2014). Not surprisingly,
GWAS studies reporting associations between mutations, copy
variants or SNPs in genes coding for AIS proteins and
neuropsychiatry disorders are rapidly emerging in the field of
brain disorders (Hsu et al., 2014). Thus, enabling technologies
and methodologies to probe for expression, pattern distribution
and localization of AIS molecules would provide a powerful tool
for investigating the biology of complex brain disorders and
designing novel therapeutics (Schafer et al., 2009; Hsu et al.,
2014).
Immunohistochemistry (IHC) coupled to fluorescence
labeling is one of the most routinely established approaches in
neuroscience and general biology laboratories. Fluorescence-
based immunolabeling typically employs a sequence of
procedures including exposing the cells/tissue specimen to
primary unlabeled antibodies against specific epitopes (the
antigen determinant of the protein of interest), followed by
fluorophor-conjugated secondary antibodies. This can provide
simultaneous multi-channel visualization of proteins in cells
and tissues through fluorescence microscopy (epifluorescence,
confocal, multiphoton, super-resolution, etc., Fritschy, 2008). In
its basic form in fixed preparations, IHC allows one to profile the
expression level and pattern distribution of given analytes across
developmental stages with cell type- and brain area-specific
precision in complex animal models and human specimens
(Breunig et al., 2007; Evers et al., 2010). If used in live tissue,
immunolabeling can also provide time course information on
protein trafficking and targeting in native conditions (Progatzky
et al., 2013; Mottillo et al., 2014). When applied to fixed tissue
specimens, optimal results in IHC depend greatly on two basic
elements: optimal fixation and tissue preservation (Schneider
Gasser et al., 2006). Of the main fixatives generally employed
in IHC (glutaraldehyde, paraformaldehyde, methanol/acetone),
paraformaldehyde at various concentrations is widely used as
it provides the most straightforward and rapid fixative method
to expose antibody epitope(s) without compromising cell/tissue
morphology (Bocksteins et al., 2012). However, detecting
proteins in fine sub-cellular structures could be challenging
using conventional fixatives (Schneider Gasser et al., 2006;
Lorincz and Nusser, 2008b, 2010; Christensen et al., 2014).
As a tight matrix of intracellular proteins, the AIS forms a
detergent-resistant membrane microdomain that can mask
epitopes and reduce antibody accessibility (Lorincz and Nusser,
2008a; Galiano et al., 2012; Gutzmann et al., 2014; Stradleigh
and Ishida, 2015). Support for this hypothesis comes from
early successes in AIS protein IHC that employied detergent
extraction methods, unconventional permeabilization (Garrido
et al., 2001, 2003), whole-brain immersion (Rasband et al.,
1999), and ultra-brief nearly without fixative (Shakkottai et al.,
2009; Shavkunov et al., 2013; Xiao et al., 2013; Bosch et al.,
2014; Tian et al., 2014). Yet, each of these methods depend
heavily on the experimenter, lead to poorly reproducible results
between laboratories and do not guarantee well-preserved cell
and tissue morphology. In addition, they are sub-optimal for
labeling with other markers unrelated to the AIS. Dual labeling
of AIS proteins with other neuronal markers has been achieved
combining standard IHC with mRNA in situ hybridization (for
AIS markers) (Brackenbury et al., 2010; Han et al., 2012; Verret
et al., 2012; Lorenzo et al., 2014), but this approach is much less
powerful for investigating protein biology.
To develop a sensitive, accurate and reproducible method for
immunolabeling of AIS markers that could be broadly applicable
to multichannel fluorescence microscopy, we have exhaustively
screened fixation recipes under ten different experimental
conditions. We initially focused on optimizing our protocol for
fluorescence-based IHC of FGF14, a member of the AIS that has
been proven especially problematic to study. We then extended
our methods especially to Nav1.6, a critical Nav channel isoform
in the brain circuit and preferential binding partner of FGF14. As
a result, we present an optimal protocol for detection of FGF14
(Wang et al., 2002; Lou et al., 2005; Laezza et al., 2007, 2009;
Xiao et al., 2007, 2013; Shakkottai et al., 2009; Shavkunov et al.,
2013; Hsu et al., 2014; Bosch et al., 2015; Tempia et al., 2015)
and other fixative-sensitive proteins that warrant high quality
detection of AIS molecules alone or in combination with cell
type-specific neuronal markers. We expect that our protocol will
have a broad impact on the neuroscience community allowing
reproducible and reliable detection of proteins that have been
otherwise undetectable.
MATERIALS AND METHODS
Animals
Fgf14+/+ and Fgf14−/− (control for FGF14 staining) mice were
maintained on an inbred C57/BL6J background (greater than ten
generations of backcrossing to C57/BL6J). Animals were bred in
the UTMB animal care facility by mating heterozygous Fgf14+/−
males and females. The University of Texas Medical Branch
operates in compliance with the United States Department of
Agriculture Animal Welfare Act, the Guide for the Care and Use
of Laboratory Animals, and IACUC approved protocols. Mice
were housed, n ≤ 5 per cage, with food and water ad libitum. All
genotypes described were confirmed by PCR analysis conducted
by our lab and/or Charles River Laboratories International.
Preparation of Brain Sections
Frozen tissue (Table 1): Adult mice were deeply anesthetized
with isoflurane (Baxter, Deerfield, IL) administered in a small
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TABLE 1 | Fixation protocols used in Option A (fresh-frozen tissue preparation).
Fixation and cutting procedures
Fresh mouse brain freezing with liquid nitrogen Option A
Cutting procedures Adhered
(Thickness) 10–15 µm
Immersion fixation
Type/Conc. 1% PFA 4% PFA Acetone Acetone 2% PFA+ 0.2% Glutaraldehyde
Time 5–10min 15min 7–10min 7min 10min
Brief fixation/Permeabilizing Acetone Acetone None Methanol Acetone
7min 7min 7min 7min
Immunofluorescence staining
Optimal protocols for AIS components detection are highlighted with green. Acetone ± MeOH methods were reproduced with two mice per group (Fgf14+/+ and Fgf14−/− ), ≤4
sections per mouse. PFA, Paraformaldehyde.
TABLE 2 | Fixation protocols used in Option B (perfused fixed tissue preparation).
Fixation and cutting procedures
Fixed brain tissue Option B
Mouse brain Fixation type/Conc. 1% PFA 1% Formaldehyde +
0.5% MeOH
(MasterTech Scientific)
4% PFA 4% PFA immersion Optimal fix*
(MasterTech
Scientific)
Post-fixation 1% PFA 1% Formaldehyde +
0.5% MeOH
4% PFA 4% PFA 4% PFA Optimal fix*
1 h 1 h 1 h 24 h 30min 1 h
Sucrose dehydration 20–30% Sucrose
Cutting procedures Adhered Adhered Adhered Free-floating Adhered Free-floating or
Adhered
(Thickness) 20–25 µm 15–25 µm 20–25 µm 25 µm 10–15µm 20–25 µm
Brief fixation/Permeabilizing Acetone Acetone Acetone None Acetone 1% triton X 100, 0.5%
tween 20 in PBS
1% triton X 100,
0.5% tween 20 in
PBS7min 7min 7min 7min
Immunofluorescence staining
Optimal protocols for AIS components detection are highlighted with green. 4% PFA+ acetone method was reproduced with four mice per group (Fgf14+/+ and Fgf14−/− ),≤3 sections
per mouse. 1% Formaldehyde + 0.5% MeOH method was reproduced with five mice per group (Fgf14+/+ and Fgf14−/−), ≤3 sections per mouse. 4% PFA immersion method was
reproduced with two mice, ≤4 sections per mouse. PFA, Paraformaldehyde, MeOH, Methanol, PBS, Phosphate-buffered solution, *Optimal fix™: Alcohol based tissue fixative that
contains 50% Ethanol, 50% Ethanediol, 1% Zinc-chloride (MasterTech Scientific).
chamber. Whole brains were then removed, frozen in liquid
nitrogen, and stored at −80◦C until use. In preparation
for sectioning, brains were embedded in OCT compound
(Tissue-Tek R©, Ted Pella, Inc., Redding, CA) and 10–15µm-
thick sagittal or coronal sequential brain sections were prepared
at −18 to −20◦C using a Leica CM1850 cryostat (Leica
Microsystems, Buffalo Grove, IL). Sections were then mounted
on glass microscope slides (Fisherbrand R© Superfrost Plus, Fisher
Scientific, Pittsburgh, PA) and stored at −80◦C. Before staining,
Frozen sections were immersed in 1%, 4% PFA, acetone alone,
acetone followed bymethanol, or 2% PFA+ 0.2%Glutaraldehyde
fixative solutions. Fixed mouse brain (Table 2): Adult mice were
first deeply anesthetized with 2,2,2-tribromoethanol (250mg/kg
i.p.; Sigma-Aldrich, Saint Louis, MO), then briefly perfused
(intra-cardiac; flow rate: 8–10ml/min for 2–5min) with cold 1X
phosphate buffer (PBS, pH= 7.4), followed by 10min of cold 1%,
4% paraformaldehyde (Sigma-Aldrich, catalog number 441244),
1% formaldehyde containing 0.5% methanol (a dilution of 37%
formaldehyde solution in PBS, MasterTech Scientific, catalog
number fxfor37gal), or Optimal Fix™ (an alcohol-based tissue
fixative that contains <50% ethanol, <50% ethanediol, <1%
Zinc-chloride; MasterTech Scientific, catalog number fxoptgal);
1% and 4% paraformaldehyde solutions were freshly prepared by
gradually dissolving paraformaldehyde (wt/vol) in warm dH2O
(50–60◦C) containing in final concentration 5N NaOH, 5M
NaCl, and 0.2M of a mixture of sodium phosphate monobasic
and dibasic (MSP/DSP). All solutions were adjusted to a pH of
7.4 and stored at 4◦C. In preparation for sectioning and to ensure
complete tissue fixation, brains were removed carefully and post-
fixed in either: 1% paraformaldehyde, 1% formaldehyde + 0.5%
methanol, Optimal Fix™ for 1 h, 4% paraformaldehyde for 1 h,
or 24 h at 4◦C and then cryopreserved in 20–30% sucrose/PBS
at 4◦C. Brains were allowed to completely sink to the bottom
of the container before sectioning. Brains were embedded in
OCT compound (Tissue-Tek R©, Ted Pella, Inc.) and sectioned
sagittally into 15–25µm-thick slices at −18 to −20◦C using
a Leica CM1850 cryostat (Leica Microsystems). Floating brain
sections (4% paraformaldehyde post-fixed for 24 h) were stored
in a cryoprotectant solution (ethylene glycol based; 30% ethylene
glycol, 30% glycerol, 10% 0.2M sodium phosphate buffer pH
7.4, in dH2O) at−20
◦C; glass slide-mounted brain section (fixed
with 1% formaldehyde contains 0.5% methanol, Optimal Fix™,
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 February 2016 | Volume 10 | Article 5
Alshammari et al. AIS and Immunostaining
or 1%, 4% paraformaldehyde post-fixed for 1 h) were stored
in−80◦C. For 4% PFA direct immersion tissue preparations were
as described previously in Rasband et al. (1999). Briefly, brains
were extracted, washed with cold 1X PBS and immersed in cold
4% PFA solution (pH ∼ 7.2) for 30min. Following incubation
in 20–30% sucrose, brains were let to sink to the bottom of the
container. Then, 10–15µm thick sagittal sections were collected
and mounted on glass microscope slides and stored at −80◦C
(for more details see Table 2, Supplementary Figures 6, 7).
Acute brain slices (Table 3): Adult mice were anesthetized with
isoflurane (Baxter) in a small chamber, then decapitated, and
coronal brain slices of 300–400µm were cut with a vibratome
VT1200S (Leica, Buffalo Grove, IL) in ice-cold regular artificial
CSF solution containing (in mM 125 NaCl, 2.5 KCl, 2 MgCl2,
2.5 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 20 glucose with
95% O2 and 5% CO2 bubbled). Then slices were transferred to
a recovery chamber with 95% O2 and 5% CO2 bubbled regular
artificial CSF containing 25µM Dimethyl sulfoxide (DMSO) at
room temperature for 2 h. Next, slices were transferred to a 24-
well plate (Greiner Bio One, North Carolina) and rinsed with
cold 1X PBS, then incubated for 30min in a 1% formaldehyde +
0.5% methanol solution (MasterTech Scientific) at 4◦C, followed
by 1-day immersion in 20–30% sucrose/PBS in preparation for
sectioning. For sectioning, coronal slices were embedded in OCT
compound and sectioned at 20–25µm using a CM1850 Leica
cryostat then mounted on glass slides (Fisher Scientific) and
stored at−80◦C until further use.
Immunofluorescence
A schematic representation of all IHC steps can be found
in Scheme 2. Day 1: free floating or glass slide-mounted
sections were washed with 1X Phosphate buffer PBS or Tris-
buffered saline TBS, then pre-incubated with permeabilizing
agent (1% Triton X-100, 0.5% Tween-20 in PBS; −20◦C acetone
and/or −20◦C methanol). Then, slices were washed extensively
with 1X PBS or 1X TBS and incubated with a blocking buffer
consisting of 10% normal goat serum NGS (Sigma-Aldrich), 5%
donkey serum DS (Santa Cruz Biotechnology, Dallas, TX) or
TABLE 3 | Fixation protocols used in Option C (acute brain slice
preparation).
Fixation and cutting procedures
Freshly prepared acute brain slices Option C
Mouse perfusion ACSF
Cutting Procedures (vibratome)
(Thickness)
Free-floating in ACSF
250–350µm
FixationType/Conc. 5min in 1X PBS followed by 30min in
1% Formaldehyde + 0.5% methanol
(Master Tech Scientific)
Sucrose dehydration 20–30% Sucrose
Cutting Procedures (Cryostat)
(Thickness)
Adhered
10–20µm
Immunofluorescence staining
Optimal protocols for AIS components detection are highlighted with green. 30min 1%
Formaldehyde + 0.5% MeOH method was reproduced with two mice, ≤3 sections per
mouse. ACSF, Artificial cerebrospinal fluid; PBS, Phosphate-buffered solution.
a mixture of 5% NGS and 3% DS in 1X TBS containing 0.3%
Triton X-100 for 1 h. This was followed by overnight incubation
at 4◦C with primary antibodies in 3% bovine serum albumin
(BSA; Sigma-Aldrich) and 1X PBS containing 0.1% Tween-20.
Primary antibodies used in this study were: mouse anti-FGF14
(1:300, NeuroMab, catalog number 75-096); IgG2a mouse anti-
Ankyrin-G (1:1000, NeuroMab, catalog number 75-146); IgG2b
mouse anti-Ankyrin-G (1:300, NeuroMab, catalog number 75-
147); chicken anti-βIV-spectrin (1:500, gift from Dr. M. Komada,
Tokyo Institute of Technology, Tokyo, Japan); rabbit anti-
parvalbumin (1:1000, Abcam catalog number Ab11427); guinea
pig anti-NeuN (1:250, Synaptic System, catalog number 266 004);
rabbit anti-calbindin (1:10000, Swant, catalog number CB38);
mouse anti-calretinin (1:3000, Swant, catalog number 6B3);
rabbit anti-PanNav (1:300, Alomone Labs, catalog number ASC-
003); mouse anti-PanNav clone K58/35 (1:300, Sigma-Aldrich,
catalog number S8809); rabbit anti-PanNav (1:300, Sigma-
Aldrich, catalog number S6936); rabbit anti-Nav1.1 (1:500,
Alomone Labs, catalog number ASC-001); mouse anti-Nav1.1
(1:500, NeuroMab, catalog number 75-023); rabbit anti-Nav1.2
(1:300, Alomone Labs, catalog number ASC-002); mouse anti-
Nav1.2 (1:300, NeuroMab, catalog number 75-024); rabbit anti-
Nav1.6 (1:300, Alomone Labs, catalog number ASC-009); mouse
anti-Nav1.6 (1:300, NeuroMab, catalog number 75-026); mouse
anti-Caspr (Neurexin IV) (1:500, NeuroMab, catalog number
75-001); mouse anti-MAP2 (1:500, Novus Biologicals, catalog
number NBP2-25156); chicken anti-MAP2 (1:500, Synaptic
System, catalog number 188 006); rabbit anti-Sox2 (1:1200,
Millipore, catalog number AB5603); goat anti-DCX (1:400,
Santa Cruz Biotechnology, catalog number sc-8066); rat anti-
BrdU (1:1000, Abcam, catalog number ab6326). Day 2: Sections
were washed five times with 1X PBS, then incubated with the
appropriate secondary antibodies (1:250, Vector Laboratories)
for 1 h in a 1X PBS solution containing 3% BSA and 0.1%
Tween-20. The following isotype-specific secondary antibodies
were used: Alexa 488-conjugated goat-anti-mouse IgG2a (for
mouse Nav1.2), Alexa 568-conjugated goat-anti-mouse IgG1
(for mouse FGF14), Alexa 568-conjugated goat-anti-mouse
IgG1 (for mouse FGF14) and Alexa 647-conjugated goat-
anti-mouse IgG2a or Alexa 488-conjugated goat-anti-mouse
IgG2b (for mouse Ankyrin-G NeuroMab, catalog number
75-146 and 75-147, respectively). After secondary antibody
incubation, tissues were washed five more times with 1X PBS
or TBS. Before mounting on Fisherbrand R© Superfrost Plus
glass microscope slides (Fisher Scientific), free-floating slices
were rinsed with water and counterstained using the nuclear
marker Topro-3 (1-3000, Life Technologies, Carlsbad, CA).
Finally, glass slides were kept in an oven at 30–32◦C for
10–15min to dry and covered using Fisherfinest R© Premium
Cover Glass (Fisher Scientific) with ProLong R© Gold anti-
fade or ProLong R© Gold anti-fade mountant with Dapi (Life
Technologies, catalog number P36941). For Bromodeoxyuridine
(BrdU) labeling, sections were incubated for 7min in cold
acetone then treated with 1 N HCL for 10min, followed by 2
N HCl for 10min at room temperature then 20min at 37◦C.
Then, slices were incubated with borate for pH correction:
0.1M borate buffer pH 8.5 for 10min at room temperature,
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 Mouse Brain 
 
Fresh-Frozen
(Option A)
Fixed Brain
(Option B)
Freshly prepared acute brain slices
(Option C)
 
Fresh tissue freezing with liquid 
nitrogen
Perfused brains/ Post-fixation
(Table 2)
Acute brain slice preparations
 
Cutting frozen sections
Adhere to glass slides
Cutting Fixed Brain
Free-floating sections or  adhere to glass 
slides
Brief immersion fixation
(Table 3)
 
Brief immersion fixation
(Table 1)
Brief immersion fixation/ Permeabilizing
Cutting Fixed tissue
Adhere to glass slides
 
Brief immersion fixation/
Permeabilizing
 
Immunofluorescence staining
(Scheme 2)
SCHEME 1 | Study design of the three options experimental procedures. Mouse brain tissues were processed following three general procedures for fixation
including Option A (fresh-frozen), Option B (perfusion-fixed), and Option C (freshly prepared acute brain slices) with up to ten variations in the type of fixative used
for perfusion through the vascular system and/or for post-fixation treatment (Tables 1–3).
followed by the glass slide-mounted section immunolabeling
procedure.
Data Reproducibility
For each protocol staining was first performed on tissue derived
from one Fgf14+/+ mouse and one Fgf14−/− as a control
replicated on at least three separate brain sections. Then, once a
protocol was elected as optimal for a given staining, experiments
were repeated and confirmed on a higher number of animals (see
legend of Tables 1–3).
Confocal Microscopy
Confocal images were acquired using a Zeiss LSM-510 META
confocal microscope with a Fluar (5x/0.25) objective, a Plan-
Apochromat (20x/0.75na) objective, a C-Apochromat (40x/1.2W
Corr) objective, and Plan-Apochromat (63x/1.46 Oil) objective.
Multitrack acquisition was performed with excitation lines at
488 nm for Alexa 488, 543 nm for Alexa 568, and 633 nm for
A647. Z-series stack confocal images were taken at fixed intervals:
0.6µm for 40x, and 0.4µm for 63x with the same pinhole setting
for all three channels; frame size was either 1024 × 1024 or
512×512 pixels. All confocal images were processed using ImageJ
US NIH (http://imagej.nih.gov/ij).
RESULTS
The most routinely used fixed tissue preparations for
immunostaining are 4% paraformaldehyde (PFA)-fixed free
floating sections (Figures 1A,a) and fresh-frozen pre-mounted
tissue slices that are captured during sectioning to adhere
gently to positively charged glass slides (Figures 1B,b). The first
method, which requires PFA perfusion of animals through the
vasculature system, provides the highest quality fixation in terms
of cellular and tissue preservation (Stradleigh and Ishida, 2015).
Figure 1a illustrates a confocal image of triple immunolabeling
of calbindin and calretinin-positive neurons along with Topro-3
nuclei staining in the mouse dentate gyrus. In this example,
there is excellent preservation of the anatomical sub-layers
and individual cell cytoarchitecture with the integrity of the
cell soma and neurites; the thin filament-like structures that
occupy the molecular layer and are visible in the green channel.
However, this technique can be problematic for AIS staining
where antigens are believed to be masked or damaged by fixation
(Mojumder et al., 2007; Tian et al., 2014). Figure 1b illustrates
an example of the distribution of the AIS protein FGF14 in the
dentate gyrus whose immunolabeling was previously shown to
require freshly frozen tissue fixation to warrant signal detection
(Shavkunov et al., 2013; Xiao et al., 2013; Bosch et al., 2015).
However, compared to PFA-fixed tissue, the dentate gyrus tissue
preservation in freshly frozen tissue (Figure 1b) was far more
limited (Figure 1a). To find an experimental condition that
could combine advantages from both preparations, we designed
a study consisting of three general classes of tissue preparations
(Scheme 1): (i) fresh-frozen (option A); (ii) perfusion-based
fixation (option B); (iii) freshly prepared acute brain slices
(option C). Within these three general procedures more than 10
experimental conditions were tested (Tables 1–3). The overall
immunostaining protocol is illustrated in (Scheme 2). As a
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-10% normal goat serum NGS
-5% donkey serum DS 
-mixture of 5% NGS and 3% DS
in 1X TBS containing 0.3% Triton X-100 
serum albumins BSA in 1X PBS containing 0.1% Tween- 20
for 1 hr  in 3% bovine serum 
albumins BSA in 1X PBS containing 0.1% Tween-20
Rinse with water and counter stained using the nuclear marker
Transfer to oven at <30°C for 10-15 min to dry and cover slip
-10% normal goat serum NGS
-5% donkey serum DS 
-mixture of 5% NGS and 3% DS
in 1X TBS containing 0.3% Triton X-100 
albumins BSA in 1X PBS containing 0.1% Tween-20
1 hr  in 3% bovine serum albumins 
BSA in 1X PBS containing 0.1% Tween-20
Rinse with water and counter stained using the nuclear marker
Transfer to oven at <30°C for 10-15 min to dry and cover slip
Overview of immunostaining  method
SCHEME 2 | Immunostaining procedure. Workflow of the general immunostaining procedure used for free floating and glass slide pre-mounted brain sections.
control for the FGF14 staining, we used tissue derived from
Fgf14−/− mice (see Supplementary Figures). We verified some
of the other tested proteins using two different antibodies
(Table 4).
Option A: Optimization of FGF14 Staining
in Fresh-Frozen Tissue
We began our study exploring different post-fixative conditions
following the fresh-frozen procedure (Option A). Mouse brains
were dissected and rapidly dipped in liquid nitrogen, then
tissue was sectioned using a cryostat set at 10–15µm thick
slices. Tissue slices were allowed to adhere to glass slides
and exposed to additional fixatives/permeabilizing agents in
five different combinations: (i) 1% PFA + acetone; (ii) 4%
PFA + acetone; (iii) acetone alone; (iv) acetone followed by
methanol; (v) 2% PFA + 0.2% glutaraldehyde followed by
acetone treatment. A summary of these procedures can be
found in Table 1. Out of the five conditions, the glutaraldehyde
mixed with paraformaldehyde fixation failed to show any
detectable FGF14 AIS immunoreactivity (data not shown).
The 1% or 4% PFA treatment did not completely prevent
FGF14 immunoreactivity at the AIS (Figures 2A,B), but was
associated with a high fluorescence background, possibly from
tissue auto-fluorescence. In contrast, the cold acetone alone
treatment improved the FGF14 immunosignal significantly at
the AIS in many brain regions including the CA3 hippocampus
(Figure 2C).
Next, we conducted a series of double staining experiments
using the latter condition, and succeeded in detecting other AIS
proteins such as βIV-spectrin in the DG (Figure 2D), Nav1.6
in the nucleus accumbens (NAc; Figure 2E) and PanNav in the
cortex (Supplementary Figure 1A). To further assess the validity
of this procedure, we conducted double staining experiments
using cell type-specific neuronal markers such as parvalbumin
(a marker of a subclass of inhibitory cells that acts as a fast
intracellular Ca2+ buffer), calbindin (a marker of a subclass of
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FIGURE 1 | Scheme and examples of routinely used brain tissue preparations for immunohistochemistry. (A) Free-floating sections of 4% PFA
perfusion-fixed mouse brain tissue are depicted in individual wells in a 24-well plate before mounting. (a) Representative confocal image of 4% PFA perfusion-fixed
sections of the hippocampal DG immunolabeled with a rabbit anti-calbindin (CB) antibody visualized with an Alexa 488-conjugated secondary antibody (green), a
mouse monoclonal anti-calretinin (CR) antibody visualized with an Alexa 568-conjugated secondary antibody (red) and Topro-3 nuclei staining (blue). (B) Fresh-frozen
mouse brain slices directly adhered to positively charged glass slides. (b) Representative confocal image of a fresh-frozen section of the hippocampal DG,
immunolabeled with a mouse monoclonal anti-FGF14 antibody visualized with an Alexa 568-conjugated secondary antibody. PFA, paraformaldehyde; DG, dentate
gyrus; ML, molecular layer; GCL, granule cell layer; SGZ, sub-granular zone. Scale bars represent 20µm.
inhibitory cells that acts as a slow intracellular Ca2+ buffer;
Chard et al., 1993) and doublecortin (a marker of immature
neurons; Brown et al., 2003). Yet, we were unable to detect
signals from any of these cell markers (data not shown). We
then attempted to improve our detection method by adding a
second post-fixation procedure by rapidly immersing acetone-
fixed slices in cold methanol. As a result, we were able to detect
a weak signal for parvalbumin in the soma (Figure 2F), but
the overall quality of the staining was suboptimal. Consistent
with previous studies from our laboratory (Shavkunov et al.,
2013), our results from fresh-frozen preparations in five different
fixation treatments suggest that cold acetone fixation with or
without a subsequent light fixation in cold methanol are ideal
conditions for AIS studies, but are sub-optimal for studying other
cell type markers.
Option B: Optimization of FGF14 Staining
Fixed Tissue
We next tested the immunostaining of FGF14 in samples
derived from tissue perfused for a short period of time (10min)
via the vascular system of the animal using different fixatives
followed by post-fixation/permeabilization treatments (Option
B). The variables that defined these different treatments included
the type of material, its concentration and/or the treatment
time (Table 2). These protocols were inspired by trial-and-
error attempts of our own laboratory experience or published
data on FGF14 (Shakkottai et al., 2009; Xiao et al., 2013;
Bosch et al., 2014, 2015). In the three conditions where the
perfused fixative concentration was weak (1% PFA, commercially
available 1% formaldehyde + 0.5% methanol, and commercially
available Optimal Fix™) we faced tissue-tearing issues and had
to use the adhered instead of free-floating tissue approach. We
posited that perfusing animals with a low concentration of
PFA might not be sufficient to maintain thin tissue sections
intact in the ethylene glycol-based cryoprotectant solution.
In the first condition, consisting of 1% PFA perfusion, the
FGF14 immunostaining at the AIS was weak, but detectable
(Figure 3A), the tissue integrity was not ideal, and the neuronal
cell type marker detection (calbindin) was suboptimal (Figure 3F
vs. Figure 1a). The second condition consisting of the 1%
formaldehyde + 0.5% MeOH (MasterTech Scientific) fixation
showed a highly distinct FGF14 signal at the AIS (Figure 3B) with
overall well-preserved tissue morphology and good neuronal
marker detection (Figure 3G). On the contrary, the routinely
used 4% PFA fixation yielded almost non-detectable FGF14
AIS signals (Figure 3C), but provided great tissue preservation
and cell type marker counterstaining (Figure 3H). Interestingly,
incubating 4% PFA perfused tissue sections with cold acetone
for <10min enhanced the detection of FGF14 signal at the AIS
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FIGURE 2 | Representative examples of double immunofluorescence staining of mouse brain fresh-frozen sections followed by the indicated
post-fixative treatments. (A) Weak detection of FGF14 immunoreactivity at the AIS (arrow) in cells in the mouse cortical region using 1% PFA post-fixed treatment
(Scheme 1, Option A, first column of Table 1). (B) Weak detection of FGF14 immunoreactivity at the AIS (arrow) in cells of the mouse cortical region using 4% PFA
post-fixed treatment (Scheme 1, Option A, second column of Table 1). (C) Optimal detection of FGF14 immunoreactivity in the CA3 hippocampal region following
acetone-based brief post-fixation treatment (Scheme 1, Option A, third column of Table 1). (D) Representative confocal images of double immunostaining of the DG
using acetone-based post-fixation treatment. The gray and red channels represent FGF14 immunoreactivity visualized with an Alexa 568-conjugated secondary
antibody. The green channel represents βIV-spectrin immunoreactivity visualized with an Alexa 488-conjugated secondary antibody. Arrows show co-localization
between FGF14 and βIV-spectrin at the AIS. Green and red channel overlay images are shown on the right. (E) Representative confocal images of double
immunostaining of the NAc using acetone-based (without methanol) post-fixation treatment (Scheme 1, Option A, third column of Table 1). The gray and red
channels represent FGF14 immunoreactivity, the green channel represents Nav1.6 (primary antibody from Alomone Labs) visualized (weakly) with an Alexa
488-conjugated secondary antibody. The blue represents Topro-3 nuclear staining shown in the green, red, and blue image overlay on the right. Arrows show
co-localization between FGF14 and Nav1.6 at the AIS. (F) Representative confocal images of double immunostaining of a zoomed area of the CA1 hippocampal
(Continued)
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FIGURE 2 | Continued
region using acetone + methanol-based post-fixation treatment (Scheme 1, Option A, fourth column of Table 1). The gray and red channels represent FGF14
immunoreactivity visualized with an Alexa 568-conjugated secondary antibody. The green channel represents parvalbumin immunoreactivity visualized with an Alexa
488-conjugated secondary antibody. Arrows show localization of FGF14 at the AIS in areas around the parvalbumin soma. Green and red channel overlay images are
shown on the right. Note an FGF14 positive halo overlays with somatic parvalbumin staining suggesting localized co-expression of the two proteins in cytoplasmic
regions. Arrows indicate FGF14, βIV-spectrin, and/or Nav1.6 signals at the axon initial segment (AIS). DG, dentate gyrus; NAc, nucleus accumbens; PFA,
paraformaldehyde. Scale bars represent 20µm.
FIGURE 3 | Representative examples of immunofluorescence staining of mouse fixed brain sections followed by indicated post-fixation treatments.
(A) 1% PFA perfused-brain fixation revealed weak detection of FGF14 at the AIS in the DG region (Scheme 1, Option B, first column of Tale 2). (B) Light fixation with
a mixture containing 1% formaldehyde and 0.5% methanol (diluted from commercially available mixture of 37% formaldehyde in PBS, pH = 7.4) resulted in robust
staining of FGF14 in the DG region (Scheme 1, Option B, second column of Table 2). (C) FGF14 immunoreactivity is almost non-detectable in the DG upon 4% PFA
perfused-fixed sections [Scheme 1, Option B, third column of Table 2 (left)]. (D) FGF14 immunoreactivity is enhanced in 4% PFA perfused-brain followed by brief
acetone post-fixation treatment [Scheme 1, Option B, third column of Table 2 (right)]. (E) FGF14 immunoreactivity is non-detectable in Optimal FixTM perfusion
conditions (Scheme 1, Option B, fifth column of Table 2). (F) The green channel represents calbindin immunoreactivity visualized with an Alexa 488-conjugated
secondary antibody in the DG. (G) Enhanced NeuN staining visualized with an Alexa 488-conjugated secondary antibody in 1% formaldehyde with 0.5% methanol
fixation in the DG. (H) Detection of parvalbumin immunoreactivity visualized with an Alexa 488-conjugated secondary antibody in the soma and dendrites with 4% PFA
fixed sections in the DG. (I) Parvalbumin immunoreactivity in the soma and dendrites in the CA3 hippocampal region using 4% PFA followed by brief acetone
post-fixation treatment. (J) Calbindin immunoreactivity in the cerebellum using Optimal FixTM perfusion. DG, dentate gyrus; PFA, paraformaldehyde. Scale bars
represent 20µm.
without compromising tissue structure (Figure 3D). In the same
preparation, parvalbumin immunoreactivity in both soma and
dendrites was well-defined (Figure 3I). In the last condition,
animals were perfused with nontoxic alcohol-based Optimal
Fix™ solution (MasterTech Scientific). This method was not
effective in revealing FGF14 staining and did not preserve the
tissue, but the resulting calbindin staining was good (Figure 3J).
From these experiments, we can conclude that 4% PFA (24 h
post-fixation in 4% PFA) + cold acetone and 1% formaldehyde
+ 0.5% MeOH (1 h post-fixation in same fixative) were two
experimental conditions that provided high detectable FGF14
signal at the AIS, and great preservation of tissue integrity.
We then conducted additional double labeling experiments in
various brain regions using either 4% PFA + cold acetone or 1%
formaldehyde+ 0.5% MeOH.
FGF14 Double Staining Using the 4% PFA
Perfusion + Post-Fix Cold Acetone Condition
Interestingly, the 4% PFA + cold acetone condition did not
elicit the same results in all brain regions. For instance, it
provided higher quality double staining (FGF14+ parvalbumin)
in the DG region (Figure 4A) and prefrontal cortex (PFC,
Figure 4B) than in the CA1 hippocampal region (Figure 4C).
Furthermore, 4% PFA + cold acetone showed good detection
of FGF14 and calbindin in the prefrontal cortex (PFC,
Supplementary Figure 5A, upper set), but not in the CA1
hippocampal region (Supplementary Figure 5A, lower set). This
discrepancy may be due to the anatomy of the CA1 hippocampal
region, where laminations are tight and denser compared to other
brain regions (Rho et al., 2010), rather than variability in FGF14
expression (Shavkunov et al., 2013).
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FIGURE 4 | Representative examples of double immunofluorescence staining of mouse brain tissue using 4% PFA perfusion and acetone-based
post-fixation treatment. For the entire figure, the gray and red channels represent FGF14 immunoreactivity visualized with an Alexa 568-conjugated secondary
antibody; the green channel represents parvalbumin immunoreactivity visualized with an Alexa 488-conjugated secondary antibody; image overlaid of the green, red,
and blue channel (representing Topro-3 nuclear staining) in the DG region (A), PFC region (B), and CA1 region (C). (C) The same staining and immunolabelling used in
(A,B) reveals a rather weak signal corresponding to FGF14 immunoreactivity, but selective parvalbumin labeling of somata and dendrites (green) in the CA1
hippocampal region. Arrows show FGF14 signals at the axon initial segment (AIS). DG, dentate gyrus; PFC, pre-frontal cortex; PFA, paraformaldehyde. Scale bars
represent 20µm.
FGF14 Double and Triple Staining Using 1%
Formaldehyde + 0.5% MeOH Perfusion Condition
Next, we extended the evaluation of our second successful
protocol consisting of intracardial perfusion with a commercially
available solution containing 1% formaldehyde + 0.5% MeOH,
then sections were immersed in lightly-fixative of cold acetone
before immunostaining. As shown in Figure 5, this condition
provided accurate detection of FGF14 in the soma and at
the AIS along with calbindin immunolabeling across the DG
(Figure 5A), subiculum (Figure 5B), cortex (Figure 5C), and
cerebellum (Figure 5D). With the same method in triple staining
experiments we successfully detected FGF14, Ankyrin-G and
NeuN immunoreactivity in the subiculum (Figure 6A), cortex
(Figure 6B), DG (Figure 6C) and the CA1 hippocampal region
(Figure 6D). We further analyzed the detection capacity of the
1% formaldehyde + 0.5% MeOH method using Microtubule-
associated protein 2 (MAP2), which labels the soma and
dendrites, in combination with calbindin and the AIS marker
Ankyrin-G. As shown in Supplementary Figures 5B,C, FGF14
immunosignals were sharply detected, along with MAP2, in well-
defined calbindin-positive cells in the DG and the cortex. Using
the same procedure, we also extended our evaluation of FGF14
staining in conjunction with cell markers of neurogenesis, some
of which are notoriously hard to work with. As a result, we
were able to detect high-quality signals for both FGF14 and
Sex Determining Region Y-Box 2 (Sox2), a marker of early
neuronal progenitors (Figure 7A), and for doublecortin (DCX),
a marker of immature neurons (Figure 7B). Consistently with
another study conducted in our laboratory, we found that the
expression pattern of FGF14 varies across different stages of adult
neurogenesis (Alshammari et al., 2015). We also attempted the
same protocol for detecting FGF14 in BrdU+ dividing stem cells
but failed to detect any signal (from FGF14 immunolabeling).
That could be due to lack of FGF14 expression in dividing
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FIGURE 5 | Representative examples of double immunofluorescence staining of mouse brain tissue using 1% formaldehyde and 0.5% MeOH fixation.
(A–D) For the entire figure, the gray and red channels represent FGF14 immunoreactivity and the green calbindin in indicated brain regions. The corresponding green
and red merged images are shown in the right column. Arrows indicate FGF14 signal at the axon initial segment (AIS). DG, dentate gyrus. Scale bars represent 20µm.
cells (although this seems unlikely since FGF14 is expressed
in Sox2 early progenitors, Figure 7A) or to interference of the
acidic treatment required for DNA denaturation and BrdU
detection with the FGF14 epitope. However, we succeeded in
detecting another AIS component, Ankyrin-G, in BrdU-positive
cells (Figure 7C).
Numerous studies indicate a prominent role of FGF14 in
regulating Nav channel targeting and function in a Nav isoform-
specific manner (Laezza et al., 2007, 2009; Diwakar et al., 2009;
Shavkunov et al., 2013; Hsu et al., 2014; Bosch et al., 2015). Thus,
we evaluated our 1% formaldehyde + 0.5% MeOH protocol
for the double labeling of FGF14 and different Nav channel
isoforms with antigens that are known for being fixative sensitive
(Mojumder et al., 2007; Tian et al., 2014). Using a panel of
PanNav, Nav1.1, Nav1.2, and Nav1.6 antibodies in combination
with FGF14 we were able to detect a sharp immunolabeling signal
from FGF14 in all brain areas examined (Figures 8A–D, red
channel), yet failed to detect signals from PanNav (Figure 8A),
Nav1.1 (Figure 8B), or Nav1.2 (Figure 8C) (except for Nav1.2
in the cerebellum (Supplementary Figure 4C). Notably, though,
highly detectable immunoreactivity was detected only for Nav1.6
found to co-localize with FGF14 at the AIS and with Caspr at the
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FIGURE 6 | Representative examples of triple immunofluorescence staining of mouse brain tissue using 1% formaldehyde and 0.5% MeOH fixation.
(A–D) For the entire figure, the gray and red channels represent FGF14 immunoreactivity, the green NeuN, and blue Ankyrin-G (NeuroMab, catalog number 75-146) in
indicated brain regions. The corresponding multichannel overlaid images are shown in the right column. DG, dentate gyrus; NeuN, Neuronal marker. Scale bars
represent 20µm.
nodes of Ranvier (Caldwell et al., 2000) in various cortical regions
(Figure 8D, Supplementary Figure 4D).
To further evaluate the strength of our findings, we examined
the performance of another method used for AIS proteins
detection (Rasband et al., 1999), which requires the brain to be
directly immersed in 4% PFA for 30min followed by an overnight
sucrose cryoprotection, and compared it to the 1% formaldehyde
and 0.5% MeOH method (Supplementary Figures 6, 7). The
performance of the two methods varied depending on the
combination of antibodies used and the brain regions examined.
For instance, in the triple immunolabeling experiment of
Supplementary Figure 6A, PanNav, spectrin and the mouse
anti-PanNav clone K58/35 (AIS of CA1 pyramidal neurons)
immunosignals were sharper with the direct 4% PFA immersed
section method compared to the 1% formaldehyde and
0.5% MeOH condition (Supplementary Figure 6B), but two
methods were comparable for the detection of FGF14 and
Ankyrin-G (Supplementary Figures 6C,D). Though, the Nav1.6
immunosignal was superior when detected in sections fixed
with 1% formaldehyde and 0.5% MeOH in double labeling
experiments (Supplementary Figures 7A,B) and single labeling
in different brain regions (Supplementary Figures 7C,D).
Furthermore, we consistently found that the tissue integrity was
much more preserved in 1% formaldehyde and 0.5% MeOH
compared to 4% PFA brief immersion in which tissue tearing
was commonly observed and laminar structures were not fully
intact (Supplementary Figure 7).
Option C: Validation of 1% Formaldehyde ±
0.5% MeOH in Live Tissue Preparation
The immunolabeling of proteins in acute brain slice preparations,
typically used for functional studies (i.e., electrophysiology), is
a desirable technique to correlate neuronal activity outcomes
with protein expression profiles. To evaluate the performance
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FIGURE 7 | Immunolabeling of FGF14 and selected neurogenesis markers in the DG using 1% formaldehyde and 0.5% MeOH fixation. (A) The gray and
red channels represent FGF14 immunoreactivity visualized with an Alexa 568-conjugated secondary antibody, and the green channel represents Sox2, or DCX in (B),
visualized with an Alexa 488-conjugated secondary antibody. Green and red channels overlaid images are shown in the right column of both (A,B). (C) The green
channel represents Ankyrin-G (NeuroMab, catalog number 75-146) visualized with an Alexa 488-conjugated secondary antibody. The red channel represents BrdU
immunoreactivity visualized with an Alexa 568-conjugated secondary antibody and the blue represents NeuN visualized with an Alexa 647-conjugated secondary
antibody. DG, dentate gyrus; Sox2, Sex determining region Y-Box 2; DCX, doublecortin; BrdU, Bromodeoxyuridine; NeuN, Neuronal marker. Scale bars represent
20µm.
of our 1% formaldehyde + 0.5% MeOH protocol in acute
brain slice preparations (in which animals were either promptly
decapitated or perfused with physiological saline solution)
∼300µm thick freshly prepared acute brain slices were
transferred to a recovery chamber for 2 h, immersed in
1% formaldehyde + 0.5% MeOH for 30min, and kept in
20–30% sucrose overnight (Table 3). The tissue was then
sectioned the following day and immunostaining performed.
As shown in Figure 9A, FGF14 was found co-localized
with Nav1.6 and Ankyrin-G in the cortex and the NAc
(Figure 9B), indicating that this fixation protocol provides
a highly sensitive tool for the detection of FGF14 and
Nav1.6 channels in fine sub-cellular structures in the brain
(Figures 9C,D).
DISCUSSION
We specifically conducted this study to: i. overcome previous
limits in detecting FGF14 immunolabeling at the AIS while
maintaining well-preserved cell and tissue morphology; ii.
validate our staining approach in different brain regions using
multiple markers; iii. further optimize the protocol for well-
known fixative-sensitive proteins such as Nav1.6, a key binding
partner of FGF14; and iv. generate a protocol suitable for post-
hoc IHC following functional electrophysiological studies. Our
overall finding is that the fixation procedure is the key step
in successfully detecting fluorescent immunolabeling signals (of
any protein) and that meticulous trial-and-error optimizations
of the fixation step to better expose the antigen can reveal
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FIGURE 8 | Co-localization of FGF14 and Nav1.6 in mouse cortex using 1% formaldehyde and 0.5% MeOH fixation. (A–D) The gray and red channels
represent FGF14 immunoreactivity visualized with an Alexa 568-conjugated secondary antibody, the green channel represents PanNav (Sigma-Aldrich, rabbit anti
PanNav, catalog number S6936) in (A), Nav1.1 (Alomone Labs) in (B), Nav1.2 (Alomone Labs) in (C), and Nav1.6 (Alomone Labs) in (D) visualized with an Alexa
488-conjugated secondary antibody and the blue represents Topro3 nuclear staining in the cortex. Right panels represent overlaid images (third column from the left)
and high magnification of boxed ROI from the merged images. Scale bars represent 20µm.
the subcellular distribution of analytes that were otherwise
undetectable with traditional protocols.
Proper fixation is critical for unmasking certain antigens
(Schneider Gasser et al., 2006; Christensen et al., 2014;
Lorenzo et al., 2014) and optimization of this step in IHC
protocols can significantly impact antibody detection specificity.
Inappropriate fixation can also lead to a non-specific signal
and high background to noise ratio diminishing the power of
immunoprobes (Schneider Gasser et al., 2006; Fritschy, 2008).
Every fixation protocol, though, has advantages and pitfalls.
For instance, the fresh-frozen tissue approach provides
preservation of chemical antigenicity, at least for some fixative-
sensitive proteins in tightly organized cellular microdomains.
However, it bears limited results for overall tissue integrity
and cellular architecture (Niki et al., 2004; Lajtha et al., 2007).
The other general method, the fixed tissue approach, relies
basically on the formaldehyde chemistry. Formaldehyde and
its derivative para-formaldehyde (PFA) are crosslinking agents
that chemically modify the free amino groups in amino acid
chains. PFA, delivered in the animal through the vasculature,
is one of the most widely used fixatives as it provides a simple
and accessible method for studying cellular localization and
expression patterns of given analytes and morphological studies
at the cellular and subcellular level (Stradleigh and Ishida, 2015).
Formaldehyde does have some drawbacks though, the major
being epitope masking (Hoetelmans et al., 2001). Studies have
recognized this problem for IHC targeting neurotransmitters
(Stradleigh and Ishida, 2015), myelin (Christensen et al., 2014),
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FIGURE 9 | Evaluation of the 1% formaldehyde + 0.5% MeOH fixation method for post-hoc analysis in acute brain slices. (A–C) The gray channel
represents FGF14 immunoreactivity visualized with an Alexa 568-conjugated secondary antibody. The green channel represents Nav1.6 (Alomone Labs) visualized
with an Alexa 488-conjugated secondary antibody, and the blue represents Ankyrin-G (NeuroMab, catalog number 75-146) visualized with an Alexa 647-conjugated
secondary antibody in the cortex at low in (A,C) and high in (B) magnification. Images in (A,B) are from the cortex while images in (C) are taken from the NAc. (D) The
red channel represents Nav1.6 (Alomone Labs) immunoreactivity visualized with an Alexa 568-conjugated secondary antibody. The green channel represents
Ankyrin-G (NeuroMab, catalog number 75–146) visualized with an Alexa 488-conjugated secondary antibody and the blue represents NeuN (visualized with an Alexa
647-conjugated secondary antibody) in the NAc. Arrows show FGF14 and/or Nav1.6 signals at the axon initial segment (AIS). NAc, nucleus accumbens. Scale bars
represent 20µm.
synapses (Schneider Gasser et al., 2006; Lorenzo et al., 2014) and
the AIS (Tian et al., 2014). Coagulant fixatives such as methanol
and acetone are yet another class of fixatives. These compounds
can lead to poor tissue preservation and limited detection of
subcellular proteins. They are known to cause dehydration
and extraction of membrane lipids (Bancroft and Stevens,
1990; Hoetelmans et al., 2001; Al-Mulla, 2011) leading to tissue
shrinkage and tearing. However, when compared to crosslinking
agents, coagulants perform better for epitope antigenicity since
coagulants do not interact covalently with amino acid residues
preventing major changes in the secondary and tertiary structure
of proteins (Al-Mulla, 2011).
The level of detail achieved by this investigation identifies two
ideal fixation conditions for triple IHC experiments targeting
FGF14 that include mixing different classes of fixatives: 1%
formaldehyde + 0.5% MeOH, and 4% PFA + cold acetone.
In addition, although some methods failed to detect FGF14
immunoreactivity, they provided satisfactory detection of other
antigens. For example, Optimal Fix™ perfusion was ideal for
calbindin staining in the cerebellum. Likewise, the 4% PFA
perfusion was optimal for parvalbumin detection in individual
neuron soma and dendritic arborization but limited for FGF14
detection. Similar suboptimal results were obtained for calbindin
and FGF14 staining following 1% PFA fixation.
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TABLE 4 | Summary table of antigens, antibodies, and corresponding immunolabeling detection performance based on fixation procedures.
Comparing distribution patterns of FGF14 and selected AIS proteins and neuronal markers using different options of tissue fixation
Target
protein
Antibody: host, dilution and
source
Fresh-frozen Option A Perfusion-fixed Option B Freshly prepared acute brain
slices Option C
Protein immunoreactivity was highly detected using
FGF14 Mouse anti-FGF14 (1:300,
NeuroMabs, catalog number
75-096)
* and ** Prominent staining in AIS
(Figures 1B, 2C–F;
Supplementary Figure 1A)
++, ++++, and ± Prominent staining in
AIS and soma (Figures 3B,D, 4–8;
Supplementary Figures 2–6)
# Prominent staining in AIS and
soma (Figures 9A–C)
Ankyrin-G Mouse anti-Ankyrin-G (1:1000,
NeuroMabs, catalog number
75-146)
Not tested ++, +++, and ± Prominent staining in
AIS (Figures 6, 7C;
Supplementary Figures 3, 5C, 6C,D)
# Prominent staining in AIS
(Figures 9A–D)
Ankyrin-G Mouse anti-Ankyrin-G (1:300,
NeuroMabs, catalog number
75-147)
* Prominent staining in AIS ‡ ++ and +++ Prominent staining in AIS # Prominent staining in AIS
β-IV-
spectrin
Chicken anti-β-IV-spectrin
(1:500, gift from Dr. M. Komada,
Tokyo Institute of Technology,
Tokyo, Japan)
* Prominent staining in AIS ‡
(Figure 2D)
++, +++, ++++, and ± Prominent
staining in AIS
(Supplementary Figures 6A,B)
Not tested
Parvalbumin Rabbit anti-Parvalbumin (1:1000,
Abcam catalog number
Ab11427)
** weak staining in the soma
(Figure 2F)
++ and ++++ Prominent staining of
somata, dendrites, and AIS; +++
Prominent staining of somata and
dendrites (Figures 3H–I, 4)
Not tested
NeuN Guinea pig anti-NeuN (1:250,
Synaptic System, catalog
number 266 004)
Not tested ++, +++, and ± Prominent staining of
somata (Figures 3G, 6, 7C;
Supplementary Figures 3, 6A)
# Prominent staining of somata
(Figure 9D)
Calbindin Rabbit anti-calbindin (1:10,000,
Swant, catalog number CB38)
Not detectable ++, +++, ++++, and +++++
Prominent staining of somata and
dendrites (Figures 1A, 3F,J, 5;
Supplementary Figures 5A,B)
Not tested
Calretinin Mouse anti-calretinin (1:3000,
Swant, catalog number 6B3)
Not tested +++ Prominent staining of somata and
dendrites (Figure 1A)
Not tested
Sox2 Rabbit anti-Sox2 (1:1200,
Millipore, catalog number
AB5603)
Not tested ++ and +++ Prominent staining of
somata (Figure 7A)
Not tested
DCX Goat anti-DCX (1:400, Santa
Cruz Biotechnology, catalog
number sc-8066)
Not detectable ++ and +++ Prominent staining of
somata and dendrites (Figure 7B)
Not tested
BrdU Rat anti-BrdU (1:1000, Abcam,
catalog number ab6326)
Not tested ++ and +++ with (DNA denaturation
protocol) Prominent staining of somata
(Figure 7C)
Not tested
PanNav Rabbit anti-PanNav (1:300,
Alomone Labs, catalog number
ASC-003)
* Prominent staining in soma and
AIS ‡
(Supplementary Figure 1A)
++ Prominent staining of somata, and
weak detection in the AIS ‡
(Supplementary Figure 4A)
# Prominent staining in the soma
PanNav Rabbit anti-PanNav (1:300,
Sigma-Aldrich, catalog number
S6936)
* (Wildburger et al., 2015;
Shavkunov et al., 2013)
++ Prominent staining of somata, and
weak detection in the AIS ‡ (Figure 8A)
# Prominent staining in the soma
PanNav Mouse anti-PanNav clone
K58/35 (1:300, Sigma-Aldrich,
catalog number S8809)
Not tested ++ Weak detection in the AIS; ±
Prominent staining in AIS
(Supplementary Figures 6A,B, 7A,B)
Not tested
Nav1.1 Rabbit anti-Nav1.1 (1:500,
Alomone Labs, catalog number
ASC-001)
* Prominent in soma and weak in
AIS ‡
++ Prominent staining of somata, and
weak detection in the AIS (Figure 8B)
# Prominent staining in the soma
and weak in AIS
Nav1.1 Mouse anti-Nav1.1 (1:500,
NeuroMab, catalog number
75-023)
Not tested ++ Prominent staining of somata, and
weak detection in the AIS
Not tested
Nav1.2 Rabbit anti-Nav1.2 (1:300,
Alomone Labs, catalog number
ASC-002)
* weak detection ‡ ++ Prominent staining in AIS of the
neurons in the cerebellum ‡ (Figure 8C;
Supplementary Figure 4C)
Not tested
(Continued)
Frontiers in Cellular Neuroscience | www.frontiersin.org 16 February 2016 | Volume 10 | Article 5
Alshammari et al. AIS and Immunostaining
TABLE 4 | Continued
Comparing distribution patterns of FGF14 and selected AIS proteins and neuronal markers using different options of tissue fixation
Target
protein
Antibody: host, dilution and
source
Fresh-frozen Option A Perfusion-fixed Option B Freshly prepared acute brain
slices Option C
Protein immunoreactivity was highly detected using
Nav1.2 Mouse anti-Nav1.2 (1:300,
NeuroMab, catalog number
75-024)
* Wildburger et al., 2015 ++ weak detection ‡
(Supplementary Figure 4B)
# weak detection
Nav1.6 Rabbit anti-Nav1.6 (1:300,
Alomone Labs, catalog number
ASC-009)
* Prominent staining in AIS ‡ ++ and ± Prominent staining in AIS and
Node of Ranvier (Figure 8D;
Supplementary Figures 4D, 7A,B)
# Prominent staining in AIS
(Figures 9A–D)
Nav1.6 Mouse anti-Nav1.6 (1:300,
NeuroMab, catalog number
75-026)
Not tested ++ Prominent staining in AIS ‡ # Prominent staining in AIS
Caspr Mouse anti-Caspr (1:500,
NeuroMab, catalog number
75-001)
Not tested ++ Prominent staining of the Node of
Ranvier ‡ (Supplementary Figure 4D)
Not tested
MAP2 Mouse anti-MAP2 (1:500, Novus
Biologicals, catalog number
NBP2-25156)
Not tested ++ Prominent staining of somata and
dendrites ‡ (Supplementary Figure 5C)
Not tested
MAP2 Chicken anti-MAP2 (1:500,
Synaptic System, catalog
number 188 006)
Not tested ++ Prominent staining of somata and
dendrites ‡
(Supplementary Figures 5A,B)
Not tested
Protein immunoreactivity was detected using the following fixation and post-fixation procedures:
*Fresh-frozen sections immersed in acetone (7 min) (Shavkunov et al., 2013; Wildburger et al., 2015).
**Fresh-frozen sections immersed in acetone (7 min) followed by methanol (7 min).
++Perfusion-fixed tissue: animal was perfused intracardially with commercially available 1% formaldehyde +%0.5 methanol (Master-Tech Scientific), then sections immersed in acetone
(7 min).
+++Perfusion-fixed tissue: animal was perfused intracardially with 4% PFA.
++++Perfusion-fixed tissue: animal was perfused intracardially with 4% PFA, and then sections immersed in acetone (7 min).
+++++Perfusion-fixed tissue: animal was perfused intracardially with commercially available Optimal FixTM (Master-Tech Scientific), and then sections immersed in acetone (7 min).
±Brains were extracted then immersed in 4% PFA for 30 min followed by incubation in 20–30% sucrose overnight. Then sections were permeabilized with 1 % Triton X-100, 0.5 %
Tween in 1X PBS for 7–10 min.
#Acute brain slices: animal was perfused intracardially with ACSF, and then slices immersed in commercially available 1% formaldehyde + 0.5 methanol (Master-Tech Scientific) (30
min), followed by overnight incubation in 20–30% sucrose, then sections immersed in acetone (7 min).
‡ Only one condition tested.
Interestingly, we found significant variations in the
requirements for fixation depending on brain areas. For
example, the 4% PFA + 7min acetone condition worked
quite efficiently for detecting FGF14 in the cortex and the
hippocampal DG region. However, these signals were harder
to detect in the hippocampal CA1 region where principal cells
are densely packed in a laminated structure that might slow
diffusion and penetration of fixative agents (Rho et al., 2010).
Indeed, FGF14 immunoreactivity in the CA1 region could be
detected, but only using a combination of 1% formaldehyde and
0.5% MeOH, likely because of the methanol effect on antigen
unmasking.
Using these improved IHCmethods we have identified FGF14
as a component of the AIS in parvalbumin, calbindin and
NeuN positive cells in multiple brain regions. We also succeeded
in visualizing FGF14 in migratory neuroblasts, doublecortin
positive cells and Sox2+ neuronal stem cells, as shown in other
studies from our laboratory (Alshammari et al., 2015). However,
we were unable to detect FGF14 signals in BrdU+ cells, possibly
because BrdU processing requires an intense acidic treatment
that might alter antigen conformation or exposure.
Previous studies have shown that FGF14 regulates different
Nav channel isoforms. FGF14 co-localizes with PanNav channels
in primary culture neurons (Lou et al., 2005; Laezza et al.,
2007, 2009; Shavkunov et al., 2013), in hippocampal and para-
hippocampal regions (Shavkunov et al., 2013), and in the axon
initial segment of cerebellar granule cells (Diwakar et al., 2009).
Our studies confirm, and expand upon, these findings in brain
areas such as the cortex and cerebellum. Our studies also
confirmed the high sensitivity of different Nav channel isoforms
to fixation and tissue preparation as previously reported in
the mammalian retina (Mojumder et al., 2007). Among all the
Nav isoforms, we were most able to greatly optimize Nav1.6
staining. For this Nav isoform, fixation with 1% formaldehyde +
0.5% MeOH leads to optimal detection in double and triple
staining experimental sets including FGF14. We confirmed
Nav1.6 staining using two different antibodies, a polyclonal anti-
rabbit (Alomone Labs) and a monoclonal mouse anti-Nav 1.6
antibody (NeuroMab). Further validation was provided using
various tissue preparations leading to a high signal overlap
between FGF14 and Nav1.6 in snap-frozen, perfusion-fixed and
acute brain slices. The Nav1.1 immunosignal at the AIS was not
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well defined in tissue fixed with 1% formaldehyde+ 0.5%MeOH,
although some immunoreactivity in the soma was detected.
This result may reflect a true sub-cellular specific distribution
of Nav1.1 with a stronger signal in the soma than at the
AIS (Gong et al., 1999; Caldwell and Levinson, 2004; Kalume
et al., 2007) or it might just indicate that further optimization
is still needed for this antigen. As for Nav1.2, we detected
Nav1.2 signal in the AIS of cells in the cerebellum where it co-
localized with FGF14 (data not shown). Previous studies in the
retina have shown that PanNav labeling is extremely sensitive
to fixation (Mojumder et al., 2007). Our studies confirmed
this report showing that immunolabeling of all Nav channels
with PanNav antibodies (raised against conserved intracellular
epitopes) was limited to 1% formaldehyde + 0.5% MeOH
fixed tissue or fresh-frozen tissue (Shavkunov et al., 2013).
Finally, we compared the 1% formaldehyde + 0.5% MeOH
with the 4% PFA whole-brain immersion method that has been
previously used to examine AIS components (Rasband et al.,
1999). Our study indicates that the two methods led to variable
results with the 4% PFA immersion method being superior for
the detection of mouse anti-PanNav (clone K58/35) and βIV-
spectrin, but comparable or inferior to the 1% formaldehyde
+ 0.5% MeOH method in the detection of Ankyrin-G, FGF14,
and NeuN or Nav1.6, respectively. Overall, though, across all
immunostainings the 1% formaldehyde + 0.5% MeOH method
resulted in much better tissue integrity compared to the 4%
PFA immersion method in which tissue tearing was commonly
observed.
CONCLUSION AND FUTURE DIRECTIONS
We have designed two ideal protocols for detecting FGF14
alone or in combination with Nav1.6 at the AIS, in double
and triple IHC experiments in multiple brain regions and cell
types. One successful method includes a modified version of the
routinely used 4% PFA perfusion fixation process. The second
one consists of 1% formaldehyde + 0.5% MeOH, a useful
approach for post-hoc IHC following electrophysiological studies.
The level of sensitivity of our methods provides new tools for
quantitative profiling of proteins in fixative-resistant cellular
microdomains such as the AIS, the node of Ranvier and pre
and post-synaptic compartments. Given the improved signal-to-
noise ratio and detection power, our methods will also improve
the performance of fluorescence-based image analysis including
tracking, segmentation, and development of algorithms for
geometrical descriptors in cell reconstruction and classification
studies (Labate et al., 2014; Ozcan et al., 2015).
TECHNICAL COMMENTS
Lightly fixed tissue tends to be thinner, fragile and more
susceptible to tearing. Direct adhering of tissue slices to positively
charged glass slides is a solution to this problem. Importantly,
a successful approach requires the tissue to be <20µm thick
to prevent tissue fall off during the staining procedure (i.e.,
permeabilization, washing, etc.) and to favor tissue adherence to
the charged side of the glass slide. Another technical spotlight
is the auto-fluorescence and high background noise associated
with cross-linking fixative agents (Stradleigh and Ishida, 2015)
which should always be taken into consideration especially when
optimizing uncharacterized antibodies. Thus, using tissue that
has been properly prepared, stored and kept under controlled
humidity conditions during the staining, and processed with the
most appropriate fixative agent/s (such as varying concentrations
of PFA accompanied by light fixation with cold acetone and/or
methanol) is one of the key ingredients to successful IHC
(Schneider Gasser et al., 2006).
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Supplementary Figure 1 | Validation of FGF14 staining using Fgf14−/−
mouse tissue fresh-frozen sections. Immunofluorescent staining of a
representative sagittal section of mouse brain showing FGF14 immunoreactivity
(gray and red) in the cortex from Fgf14+/+ and Fgf14−/− mice in combination
with PanNav in green channel (Alomone Labs). The arrows show co-localization of
FGF14 and PanNav at axon initial segment (AIS) in Fgf14+/+, but not Fgf14−/−
tissue. Scale bars represent 20µm.
Supplementary Figure 2 | Validation of FGF14 staining using Fgf14−/−
mouse tissue using 4% PFA with light acetone fixation. Immunofluorescent
staining of a representative sagittal section of mouse brain showing FGF14
immunoreactivity (gray and red) in the PFC from Fgf14+/+ and Fgf14−/− mice in
combination with Topro3 (blue) nuclear staining in blue. The arrows show FGF14
staining at the axon initial segment (AIS) in Fgf14+/+, but not Fgf14−/− tissue.
Scale bars represent 20µm.
Supplementary Figure 3 | Validation of FGF14 staining using Fgf14−/−
mouse tissue using 1% formaldehyde + 0.5% MeOH followed by light
acetone fixation. Immunofluorescent staining of a representative sagittal section
of mouse brain showing FGF14 immunoreactivity (gray and red) in the CA1
hippocampal region from Fgf14+/+ and Fgf14−/− mice in combination with
Ankyrin-G (blue) and NeuN (green). The arrows show co-localization of FGF14 and
Ankyrin-G at axon initial segment (AIS) in Fgf14+/+, but not Fgf14−/− tissue.
Scale bars represent 20µm.
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Supplementary Figure 4 | FGF14 and Nav1 α-subunit-specific antibodies
staining perfusion-fixed tissue preparations (1% formaldehyde +0.5%
MeOH) followed by light acetone fixation. (A–C) Representative
immunostaining of FGF14 (gray and red) in combination with PanNav (Alomone
Labs) in the cortex A, Nav1.2 (NeuroMab) in the subiculum (B), and cerebellum (C),
all shown in green. Topro3 nuclear staining from sagittal sections of Fgf14+/+ mice
is shown in blue. Arrows show localization of FGF14 at axon initial segment (AIS);
note co-localization with Nav1.2 only in the cerebellum (C). (D) Green channel
shows Nav1.6 (Alomone Labs) clustering at the nodes of Ranvier (arrowheads) label
with Caspr (red) in the cortical region. Scale bars represent 20µm.
Supplementary Figure 5 | FGF14, Ankyrin-G, calbindin, and MAP2 staining
using 4% PFA + acetone, and 1% formaldehyde + 0.5% MeOH fixation
conditions. (A,B) The gray and red channels represent FGF14 immunoreactivity
visualized with an Alexa 568-conjugated secondary antibody. The green channel
represents calbindin [gray and green in (B)] visualized with an Alexa
488-conjugated secondary in combination with MAP2 [Synaptic System; blue in
(A), gray and blue in (B)] visualized with an Alexa 647-conjugated secondary
antibody using 4% PFA + acetone fixation from prefrontal cortex (PFC) and
hippocampal CA1 regions in A, and 1% formaldehyde + 0.5% MeOH from the
dentate gyrus in (B). (C) The green channel represents Ankyrin-G (NeuroMab,
catalog number 75–146) visualized with an Alexa 647-conjugated secondary
antibody. The red channel represents MAP2 immunoreactivity (Novus Biologicals)
visualized with an Alexa 568-conjugated secondary antibody using 1%
formaldehyde + 0.5% MeOH fixation. Arrows show localization of FGF14 or
Ankyrin-G at axon initial segment (AIS). Scale bars represent 20µm.
Supplementary Figure 6 | Comparing 1% formaldehyde + 0.5% MeOH to
the 4% PFA immersion fixation to detect AIS components. (A,C)
represent 4% PFA immersion fixation (Scheme 1, Option B, forth column of
Table 2). (B,D) represent 1% formaldehyde and 0.5% methanol fixation
(Scheme 1, Option B, second column of Table 2). In (A,B) the gray and red
channel show PanNav clone K58/35 visualized with an Alexa 568-conjugated
secondary antibody in combination with βIV-spectrin in the green channel
(visualized with an Alexa 488-conjugated secondary antibody) and NeuN in the
blue channel. Arrows show co-localization between PanNav and βIV-spectrin at
the AIS. In (C,D) the gray and red channel show FGF14 visualized with an
Alexa 568-conjugated secondary antibody in combination with Ankyrin-G in the
green channel (visualized with an Alexa 488-conjugated secondary antibody).
Arrows show co-localization between FGF14 and Ankyrin-G at the AIS. Scale
bars represent 20µm.
Supplementary Figure 7 | Nav1.6 and PanNav detection using 1%
formaldehyde + 0.5% MeOH and 4% PFA immersion fixation conditions.
(A) The gray and green channel show Nav1.6 (Alomone Labs) visualized with an
Alexa 488-conjugated secondary antibody in combination with PanNav clone
K58/35 in gray and red channel visualized with an Alexa 568-conjugated
secondary antibody using 1% formaldehyde + 0.5% methanol fixation or 4% PFA
immersion fixation in (B). (C,D) The gray channel shows Nav1.6 in different brain
regions using 1% formaldehyde + 0.5% methanol fixation or 4% PFA immersion
fixation in (D). Arrows show co-localization between Nav1.6 and PanNav at the
AIS. Asterisks indicate tissue tearing visible in the 4% PFA immersion method.
Scale bars represent 20, 40µm in (D).
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